DE69621706T2 - Verwendung von Piperazinverbindungen als narkotische Antagonisten - Google Patents

Verwendung von Piperazinverbindungen als narkotische Antagonisten

Info

Publication number
DE69621706T2
DE69621706T2 DE69621706T DE69621706T DE69621706T2 DE 69621706 T2 DE69621706 T2 DE 69621706T2 DE 69621706 T DE69621706 T DE 69621706T DE 69621706 T DE69621706 T DE 69621706T DE 69621706 T2 DE69621706 T2 DE 69621706T2
Authority
DE
Germany
Prior art keywords
piperazine compounds
narcotic antagonists
narcotic
antagonists
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69621706T
Other languages
English (en)
Other versions
DE69621706D1 (de
Inventor
Masato Inazu
Mariko Harada
Tomoko Masuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Publication of DE69621706D1 publication Critical patent/DE69621706D1/de
Application granted granted Critical
Publication of DE69621706T2 publication Critical patent/DE69621706T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69621706T 1995-07-11 1996-07-03 Verwendung von Piperazinverbindungen als narkotische Antagonisten Expired - Fee Related DE69621706T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17456695A JP3571114B2 (ja) 1995-07-11 1995-07-11 麻薬拮抗剤

Publications (2)

Publication Number Publication Date
DE69621706D1 DE69621706D1 (de) 2002-07-18
DE69621706T2 true DE69621706T2 (de) 2002-10-24

Family

ID=15980810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69621706T Expired - Fee Related DE69621706T2 (de) 1995-07-11 1996-07-03 Verwendung von Piperazinverbindungen als narkotische Antagonisten

Country Status (7)

Country Link
US (1) US6100280A (de)
EP (1) EP0755680B1 (de)
JP (1) JP3571114B2 (de)
AU (1) AU699544B2 (de)
CA (1) CA2180085A1 (de)
DE (1) DE69621706T2 (de)
ES (1) ES2177697T3 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1051433A (en) * 1974-01-23 1979-03-27 Hitoshi Uno 1-substituted-4-(1,2-diphenylethyl)piperazine derivatives and their salts and the preparation thereof
TW205034B (de) * 1990-09-13 1993-05-01 Pola Kasei Kogyo Kk
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
DE69426771T2 (de) * 1993-06-25 2001-06-13 Pola Chem Ind Inc Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms
JP3331046B2 (ja) * 1993-06-25 2002-10-07 ポーラ化成工業株式会社 脳脂質過酸化抑制剤
JP3547796B2 (ja) * 1993-06-25 2004-07-28 ポーラ化成工業株式会社 セロトニン取込み阻害剤

Also Published As

Publication number Publication date
AU699544B2 (en) 1998-12-03
DE69621706D1 (de) 2002-07-18
CA2180085A1 (en) 1997-01-12
EP0755680B1 (de) 2002-06-12
EP0755680A2 (de) 1997-01-29
US6100280A (en) 2000-08-08
EP0755680A3 (de) 1998-01-14
JP3571114B2 (ja) 2004-09-29
ES2177697T3 (es) 2002-12-16
JPH0920664A (ja) 1997-01-21
AU5613196A (en) 1997-01-23

Similar Documents

Publication Publication Date Title
DE69332898D1 (de) 4-Carboxamidopiperidinderivate und ihre Verwendung als Neurokinin Antagonisten
DE59905858D1 (de) Verwendung von pit-emulsionen
DE69715827T2 (de) Verwendung von aloe extrakt enthaltenden zahnprothesehaftmitteln
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
ATE288207T1 (de) Verwendung von 1-nonen-3-one als aromastoff
DE69617995D1 (de) Indolalkylderivate von benzodioxanmenthylamin als 5-ht1a rezeptor liganden
DE59409777D1 (de) Verwendung von Acrylamidpolymeren als Faltenverhinderungsmittel
DE69801878T2 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
DE69626416D1 (de) Salze von chinolinderivaten als nk3 antagonisten
ATE196294T1 (de) Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste
DE69827393D1 (de) Kosmetische verwendung von bis-resorcinol-triazinderivaten
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
ATE181071T1 (de) Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel
DE59701610D1 (de) Verwendung von sarkosinaten als asphalten-dispergatoren
DE59502125D1 (de) Verwendung von lösungsmittelfesten textilbindern
ATE325118T1 (de) Piperazinoderivate als neurokinin-antagonisten
DE69513864D1 (de) Verwendung von Polyketon /HDPE Mischungen
DE59813467D1 (de) Verwendung von aerogelen als adsorptionsmittel
DE59508900D1 (de) Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide
ATE230983T1 (de) Neue verwendung von kreatin
DE69621706T2 (de) Verwendung von Piperazinverbindungen als narkotische Antagonisten
DE69313554T2 (de) Verwendung von Tetrahydro-4-methyl-2-phenyl-2H-pyran als Riechstoff
DE59802138D1 (de) Verwendung von wachs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee